BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20567116)

  • 1. [A case of advanced esophageal cancer with no recurrence treated biweekly with postoperative docetaxel/nedaplatin combined chemotherapy after non-curative surgery].
    Sugimoto K; Sasaki K; Karaki H; Okaya T; Suzuki H; Hayashi S; Yamamoto K; Yamamori H; Sugano I
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1101-3. PubMed ID: 20567116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
    Kanekiyo S; Takeda S; Nakajima M; Nishiyama M; Kitahara M; Shindou Y; Michihisa I; Abe T; Yoshino S; Hazama S; Nagano H
    Anticancer Res; 2016 Apr; 36(4):1923-7. PubMed ID: 27069181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of biweekly nedaplatin in combination with docetaxel as second-line chemotherapy in patients with unresectable or recurrent esophageal cancer].
    Irino T; Egawa T; Kenmochi T; Ito Y; Mihara K; Okamura A; Eto E; Inaba Y; Murakawa M; Nagashima A
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2401-4. PubMed ID: 22202395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An elderly hemodialytic case of recurrent esophageal cancer given combination chemotherapy with docetaxel and nedaplatin who showed temporal relief of swallowing disturbance].
    Miura T; Hosojima Y; Nakamura J; Yamada S; Nakazawa Y; Ozeki Y; Miura T; Yanagi M; Yamazaki H; Takahashi T
    Gan To Kagaku Ryoho; 2010 May; 37(5):883-5. PubMed ID: 20495320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil].
    Matsutani T; Uchida E; Maruyama H; Suzuki S; Yokoyama T; Matsushita A; Hirakata A; Kawamoto M; Arai H; Umakoshi M; Wakabayashi H; Sasajima K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1949-52. PubMed ID: 20948262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
    Tanaka Y; Yoshida K; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K
    Cancer Sci; 2016 Jun; 107(6):764-72. PubMed ID: 27061001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced esophageal carcinoma with nephrotic syndrome completely responding to chemotherapy of docetaxel, nedaplatin and 5-fluorouracil].
    Matsutani T; Uchida E; Yoshida H; Suzuki S; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Kawamoto M; Arai H; Umakoshi M; Wakabayashi H; Sasajima K
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):439-41. PubMed ID: 21403450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.
    Osaka Y; Takagi Y; Hoshino S; Tachibana S; Tsuchida A; Aoki T
    Dis Esophagus; 2006; 19(6):473-6. PubMed ID: 17069591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined therapy with docetaxel and nedaplatin for relapsed and metastatic esophageal carcinoma.
    Matsumoto H; Hirabayashi Y; Kubota H; Murakami H; Higashida M; Haruma K; Hiratsuka J; Nakamura M; Hirai T
    Anticancer Res; 2012 May; 32(5):1827-31. PubMed ID: 22593469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer].
    Kawada J; Iwase K; Deguchi K; Higashi S; Deguchi T; Matsuda C; Tamagawa H; Omori K; Nishikawa K; Nomura M; Takagi M; Fukui A; Tanaka Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2095-7. PubMed ID: 23267988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
    Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy.
    Asaka S; Shimakawa T; Yamaguchi K; Murayama M; Shimazaki A; Katsube T; Naritaka Y
    Anticancer Res; 2016 Nov; 36(11):6165-6171. PubMed ID: 27793947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of combination chemotherapy with docetaxel and nedaplatin in patients with advanced or recurrent esophageal cancer].
    Funaki H; Miura S; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2384-6. PubMed ID: 25731531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of double advanced cancer with esophageal and hypopharyngeal carcinoma responding completely to combination chemotherapy of docetaxel/5-fluorouracil and nedaplatin with radiation].
    Matsutani T; Sasajima K; Kobayashi Y; Suzuki S; Maruyama H; Miyamoto M; Yokoyama T; Sugiura A; Matsushita A; Yanagi K; Matsuda A; Arai H; Nishi Y; Wakabayashi H; Tajiri T
    Gan To Kagaku Ryoho; 2009 May; 36(5):835-8. PubMed ID: 19461189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of docetaxel and nedaplatin combined with concurrent intensity modulated radiation therapy in the treatment of esophageal cancer].
    Bi LW; Zhang LZ; Zhao HF
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):710-1. PubMed ID: 23159088
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of liver metastasis from esophageal cancer treated with stereotactic body radiation therapy].
    Egawa T; Okubo Y; Kemmochi T; Mori T; Sato S; Nishiya S; Mihara K; Ito Y; Makino H; Nagashima A
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1850-2. PubMed ID: 24393943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of recurrent esophageal cancer with lung metastases successfully treated with docetaxel-combination chemotherapy].
    Kobayashi Y; Sugitani S; Morita S; Nonaka M; Saito Y; Fujiwara S; Hori T; Iiri T
    Gan To Kagaku Ryoho; 2006 May; 33(5):655-7. PubMed ID: 16685166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T; Sakayori M; Kato S; Chiba N; Miyazaki S; Nemoto K; Shibata H; Shimodaira H; Ohtsuka K; Kakudo Y; Sakata Y; Ishioka C
    Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
    Morimoto J; Oohira M; Kubo N; Tanaka H; Dan N; Muguruma K; Yashiro M; Sawada T; Yamashita Y; Nishiguchi Y; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2436-8. PubMed ID: 20037448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.